Citadel Advisors LLC Acquires Shares of 78,961 Bolt Biotherapeutics, Inc. (NASDAQ:BOLT)
Citadel Advisors LLC bought a new position in shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 78,961 shares of the company’s stock, valued at approximately $42,000. Bolt Biotherapeutics Price Performance BOLT opened at $6.53 […]
Citadel Advisors LLC bought a new position in shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 78,961 shares of the company’s stock, valued at approximately $42,000. Bolt Biotherapeutics Price Performance BOLT opened at $6.53 […]
